​

ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

ANI Pharmaceuticals Ownership Summary

ANI Pharmaceuticals is owned by 110.82% institutional investors, 5.45% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.15% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.89% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockANI Pharmaceuticals110.82%5.45%-16.27%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.33%15.05%50.62%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de2.96M14.15%$244.92M
Blackrock2.66M13.91%$169.17M
Vanguard group1.31M6.50%$103.02M
Soleus capital management867.76K4.15%$71.83M
Vanguard capital management838.22K4.01%$69.39M
State street831.65K3.98%$68.86M
Tang capital management707.50K3.38%$58.57M
Dimensional fund advisors lp623.46K2.98%$51.61M
American century companies574.47K2.75%$47.55M
Arrowstreet capital, limited partnership562.02K2.69%$46.52M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Global alpha capital management558.00K2.77%$46.19M
Tang capital management707.50K2.66%$58.57M
Soleus capital management867.76K2.48%$71.83M
Ikarian capital272.08K2.43%$22.52M
Ranger investment management343.15K1.80%$28.41M
Parkman healthcare partners202.91K1.72%$16.80M
Sio capital management97.31K1.33%$8.05M
Marathon capital management71.99K1.21%$5.96M
Globeflex capital l p108.57K1.15%$8.99M
Aurora investment counsel26.89K1.15%$2.23M

Top Buyers

HolderShares% AssetsChange
American century companies574.47K0.02%382.90K
Rubric capital management lp258.13K0.20%258.13K
Sixth street partners management company252.57K0.00%252.57K
Divisadero street capital management, lp234.22K0.94%234.22K
Blackrock funding, inc. /de2.96M0.00%211.15K

Top Sellers

HolderShares% AssetsChange
Goldentree asset management lp---667.98K
Deep track capital, lp---600.00K
Balyasny asset management---205.09K
Ubs group297.54K0.00%-200.16K
Apis capital advisors---196.00K

New Positions

HolderShares% AssetsChangeValue
Rubric capital management lp258.13K0.20%258.13K$21.37M
Sixth street partners management company252.57K0.00%252.57K$20.91M
Divisadero street capital management, lp234.22K0.94%234.22K$21.45M
Dana investment advisors109.94K0.24%109.94K$9.10M
Winton group55.06K0.15%55.06K$4.56M

Sold Out

HolderChange
Tortoise investment management-1.00
Nelson, van denburg & campbell wealth management group-1.00
Mendota financial group-1.00
Financial gravity asset management-1.00
Cbiz investment advisory services-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20263128.71%23,177,347-0.92%1100.81%17212.42%893.49%
Mar 31, 2026132-54.79%6,340,720-70.04%310.28%71-56.97%36-52.63%
Dec 31, 202583-69.71%3,388,014-83.40%160.16%37-74.66%27-67.86%
Sep 30, 202599-55.61%3,677,102-80.25%180.21%49-57.76%29-57.97%
Jun 30, 2025224-2.18%19,142,922-4.15%960.93%1145.56%70-4.11%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.11M4.89%768.00
Vanguard US Total Market Shares ETF588.25K2.73%-
Vanguard Morn Total Stk Mkt Idx Investor609.43K2.68%8.50K
Vanguard Total Stock Mkt Idx Inv609.43K2.68%8.50K
Pacer US Small Cap Cash Cows 100 ETF549.63K2.62%-1.87K
Avantis US Small Cap Value ETF535.55K2.36%3.00K
iShares Russell 2000 ETF516.00K2.27%-9.12K
Delaware Ivy Small Cap Growth C336.40K1.60%-
Macquarie Small Cap Growth C264.83K1.22%-
CC&L Global Alpha - Series A272.55K1.20%-876.00

Recent Insider Transactions

DateNameRoleActivityValue
Aug 13, 2026Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$37.74K
Aug 10, 2026Gutwerg Ori SVP, GENERICSSell$243.47K
Jul 29, 2026CAREY STEPHEN P. SVP & CFOSell$231.88K
Jul 13, 2026Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$40.92K
Jul 02, 2026CAREY STEPHEN P. SVP & CFOSell$284.92K

Insider Transactions Trends

DateBuySell
2026 Q3-5
2026 Q2-11
2026 Q1-18
2025 Q4-8
2025 Q3-22

ANIP Ownership FAQ

Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 110.82%, followed by 5.45% insiders and -16.27% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.33%, which ANI Pharmaceuticals exceeds.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (2.96M shares, 14.15%), Blackrock (2.66M shares, 13.91%), and Vanguard group (1.31M shares, 6.50%). Together, they hold 34.56% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Global alpha capital management is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.77% of its assets in 558K ANI Pharmaceuticals shares, valued at 46.19M$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 4.89% of its total shares outstanding invested in 1.11M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools